{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:40:26Z","timestamp":1791668426061,"version":"4.3.4"},"reference-count":236,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ijpharm.2024.125055","type":"journal-article","created":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T16:18:13Z","timestamp":1733588293000},"page":"125055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Peptide-based inhibitors and nanoparticles: Emerging therapeutics for Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"669","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7260-9120","authenticated-orcid":false,"given":"Solmaz","family":"Mojarad-Jabali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1139-4909","authenticated-orcid":false,"given":"Kyung-Ho","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2024.125055_b0005","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1073\/pnas.1421961112","article-title":"Zinc as chaperone-mimicking agent for retardation of amyloid \u03b2 peptide fibril formation","volume":"112","author":"Abelein","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0010","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s10571-022-01230-7","article-title":"Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease","volume":"43","author":"Aillaud","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13195-022-00959-z","article-title":"A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro","volume":"14","author":"Aillaud","year":"2022","journal-title":"Alzheimers. Res. Ther."},{"key":"10.1016\/j.ijpharm.2024.125055_b0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.molimm.2018.06.267","article-title":"Blood-brain barrier (BBB) and the complement landscape","volume":"102","author":"Alexander","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0025","series-title":"Nanotechnology-based targeted drug delivery systems for brain tumors","first-page":"75","article-title":"Active targeted nanoscale delivery systems for brain tumor therapeutics","author":"Alibolandi","year":"2018"},{"key":"10.1016\/j.ijpharm.2024.125055_b0030","unstructured":"Allon, N., Gavish, M., Veenman, J.A., 2014. Liposomes for in vivo delivery. WO Patent No 2014\/0776709 A1."},{"key":"10.1016\/j.ijpharm.2024.125055_b0035","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s00284-021-02398-9","article-title":"Phage Display Technique as a Tool for Diagnosis and Antibody Selection for Coronaviruses","volume":"78","author":"Anand","year":"2021","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113270","article-title":"Caffeic acid loaded into engineered lipid nanoparticles for Alzheimer's disease therapy","volume":"225","author":"Andrade","year":"2023","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2024.125055_b0040","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1039\/C5MB00280J","article-title":"Engineering of a peptide probe for \u03b2-amyloid aggregates","volume":"11","author":"Aoraha","year":"2015","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ijpharm.2024.125055_b0045","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ijpharm.2024.125055_b0050","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1021\/acschemneuro.9b00468","article-title":"Identification of a novel multifunctional ligand for simultaneous inhibition of amyloid-beta (A\u03b242) and chelation of zinc metal ion","volume":"10","author":"Asadbegi","year":"2019","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/j.ijpharm.2024.125055_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120861","article-title":"Alzheimer\u2019s disease failed clinical trials","volume":"306","author":"Asher","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0060","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.peptides.2003.08.005","article-title":"The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide","volume":"24","author":"Ashur-Fabian","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.ijpharm.2024.125055_b0065","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1021\/bi0358824","article-title":"Copper Mediates Dityrosine Cross-Linking of Alzheimer\u2019s Amyloid-\u03b2","volume":"43","author":"Atwood","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpharm.2024.125055_b0070","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1021\/bi701415b","article-title":"Designing Peptide Inhibitors for Oligomerization and Toxicity of Alzheimer\u2019s \u03b2-Amyloid Peptide","volume":"47","author":"Austen","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpharm.2024.125055_b0075","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/pharmaceutics14020224","article-title":"An Overview of Nanotechnologies for Drug Delivery to the Brain","volume":"14","author":"Ayub","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2024.125055_b0080","series-title":"Molecular Neurobiology","article-title":"Multifunctional Nanocarriers for Alzheimer\u2019s Disease: Befriending the Barriers","author":"Azam","year":"2024"},{"key":"10.1016\/j.ijpharm.2024.125055_b0085","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1523\/JNEUROSCI.0284-14.2014","article-title":"Multifunctional Liposomes Reduce Brain \u03b2-Amyloid Burden and Ameliorate Memory Impairment in Alzheimer\u2019s Disease Mouse Models","volume":"34","author":"Balducci","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0090","first-page":"1583","article-title":"Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect A\u03b2 aggregation features and cross the blood\u2013brain-barrier: Implications for therapy of Alzheimer disease. Nanomedicine Nanotechnology","volume":"10","author":"Bana","year":"2014","journal-title":"Biol. Med."},{"key":"10.1016\/j.ijpharm.2024.125055_b0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1755-5949.2010.00231.x","article-title":"Clioquinol: Review of its Mechanisms of Action and Clinical Uses in Neurodegenerative Disorders","volume":"18","author":"Bareggi","year":"2012","journal-title":"CNS Neurosci. Ther."},{"issue":"4","key":"10.1016\/j.ijpharm.2024.125055_b0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10989-023-10524-3","article-title":"Strategic approaches to improvise peptide drugs as next generation therapeutics","volume":"29","author":"Barman","year":"2023","journal-title":"International journal of peptide research and therapeutics"},{"key":"10.1016\/j.ijpharm.2024.125055_b0105","first-page":"1","article-title":"Peptide-Based Materials That Exploit Metal Coordination","volume":"24","author":"Bassan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0110","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1021\/cn900019r","article-title":"Effects of Peptides Derived from Terminal Modifications of the A\u03b2 Central Hydrophobic Core on A\u03b2 Fibrillization","volume":"1","author":"Bett","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0115","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1083\/jcb.101.4.1371","article-title":"The distribution of tau in the mammalian central nervous system","volume":"101","author":"Binder","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0120","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1073\/pnas.222681699","article-title":"Amyloid \u03b2-protein (A\u03b2) assembly: A\u03b240 and A\u03b242 oligomerize through distinct pathways","volume":"100","author":"Bitan","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0125","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1523\/JNEUROSCI.16-11-03601.1996","article-title":"Tau Is Enriched on Dynamic Microtubules in the Distal Region of Growing Axons","volume":"16","author":"Black","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.lfs.2012.12.004","article-title":"Effects of \u03b2-sheet breaker peptides on altered responses of thoracic aorta in rats\u2019 Alzheimer\u2019s disease model induced by intraamygdaloid A\u03b240","volume":"92","author":"B\u00f6l\u00fckba\u015f\u0131 Hatip","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0135","doi-asserted-by":"crossref","first-page":"13222","DOI":"10.1038\/srep13222","article-title":"QIAD assay for quantitating a compound\u2019s efficacy in elimination of toxic A\u03b2 oligomers","volume":"5","author":"Brener","year":"2015","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ijpharm.2024.125055_b0140","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.peptides.2010.07.015","article-title":"Molecular dynamics simulations of A\u03b2 fibril interactions with \u03b2-sheet breaker peptides","volume":"31","author":"Bruce","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.ijpharm.2024.125055_b0145","doi-asserted-by":"crossref","first-page":"34874","DOI":"10.1074\/jbc.M212694200","article-title":"Stereoselective Interactions of Peptide Inhibitors with the \u03b2-Amyloid Peptide","volume":"278","author":"Chalifour","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0150","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1002\/anie.201506225","article-title":"Blocking of the PD-1\/PD-L1 Interactionbya d-Peptide Antagonist for Cancer Immunotherapy","volume":"54","author":"Chang","year":"2015","journal-title":"Angew. Chemie Int. Ed."},{"key":"10.1016\/j.ijpharm.2024.125055_b0155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tips.2019.11.001","article-title":"Overcoming the Brain Barriers: From Immune Cells to Nanoparticles","volume":"41","author":"Charabati","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2023.06.020","article-title":"A possible mechanism for the enhanced toxicity of beta- \u00ad amyloid protofibrils in Alzheimer \u2019 s disease","volume":"120","author":"Chen","year":"2023","journal-title":"Neuroscience"},{"key":"10.1016\/j.ijpharm.2024.125055_b0165","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","article-title":"Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits \u03b2-Amyloid Accumulation in Alzheimer\u2019s Disease Transgenic Mice","volume":"30","author":"Cherny","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.ijpharm.2024.125055_b0170","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.7150\/ijms.21875","article-title":"Peptides as therapeutic agents for dengue virus","volume":"14","author":"Chew","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0175","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/mp.2017.108","article-title":"Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer\u2019s disease dementia","volume":"23","author":"Chiotis","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ijpharm.2024.125055_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chemphyslip.2017.10.003","article-title":"Production of low molecular collagen peptides-loaded liposomes using different charged lipids","volume":"209","author":"Chun","year":"2017","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ijpharm.2024.125055_b0185","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","article-title":"Tau-targeting therapies for Alzheimer disease: current status and future directions","volume":"19","author":"Congdon","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0190","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2013.00114","article-title":"Are Tau Aggregates Toxic or Protective in Tauopathies?","volume":"4","author":"Cowan","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0200","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1471-4159.2009.05870.x","article-title":"Restored degradation of the Alzheimer\u2019s amyloid-\u03b2 peptide by targeting amyloid formation","volume":"108","author":"Crouch","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0205","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1749-6632.2000.tb06938.x","article-title":"Metal chelation as a potential therapy for Alzheimer\u2019s disease","volume":"920","author":"Cuajungco","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0210","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1021\/ic9012334","article-title":"Metal Loading Capacity of A\u03b2 N-Terminus: a Combined Potentiometric and Spectroscopic Study of Zinc(II) Complexes with A\u03b2(1\u201316), Its Short or Mutated Peptide Fragments and Its Polyethylene Glycol\u2212ylated Analogue","volume":"48","author":"Damante","year":"2009","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0215","doi-asserted-by":"crossref","first-page":"e0167432","DOI":"10.1371\/journal.pone.0167432","article-title":"Selection and Characterization of Tau Binding \u1d05-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease","volume":"11","author":"Dammers","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2024.125055_b0220","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s40262-013-0079-0","article-title":"Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides","volume":"52","author":"Diao","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijpharm.2024.125055_b0225","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/prot.340160309","article-title":"A Comparison of the Immunogenicity of a Pair of Enantiomeric Proteins","volume":"16","author":"Dintzis","year":"1993","journal-title":"Funct. Bioinforma."},{"key":"10.1016\/j.ijpharm.2024.125055_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22168677","article-title":"Recent Applications of Retro-Inverso Peptides","volume":"22","author":"Doti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0235","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0301-0082(00)00068-X","article-title":"Cerebral microvascular pathology in aging and Alzheimer \u2019 s disease","volume":"64","author":"Farkas","year":"2001","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.ijpharm.2024.125055_b0240","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neurobiolaging.2007.07.015","article-title":"Blood\u2013brain barrier: ageing and microvascular disease\u2013systematic review and meta-analysis","volume":"30","author":"Farrall","year":"2009","journal-title":"Neurobiology of aging"},{"key":"10.1016\/j.ijpharm.2024.125055_b0245","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jconrel.2022.03.019","article-title":"Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers","volume":"345","author":"Farshbaf","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2024.125055_b0250","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nrn1671","article-title":"The neurobiology of zinc in health and disease","volume":"6","author":"Frederickson","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0255","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbrep.2015.07.017","article-title":"Effect of methionine-35 oxidation on the aggregation of amyloid-\u03b2 peptide","volume":"3","author":"Friedemann","year":"2015","journal-title":"Biochem. Biophys. Reports"},{"key":"10.1016\/j.ijpharm.2024.125055_b0260","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/ange.200802123","article-title":"Cognitive-Performance Recovery of Alzheimer\u2019s Disease Model Mice by Modulation of Early Soluble Amyloidal Assemblies","volume":"121","author":"Frydman-Marom","year":"2009","journal-title":"Angew. Chemie"},{"key":"10.1016\/j.ijpharm.2024.125055_b0265","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1021\/cn100057j","article-title":"Oral Treatment with the <scp>d<\/scp> -Enantiomeric Peptide D3 Improves the Pathology and Behavior of Alzheimer\u2019s Disease Transgenic Mice","volume":"1","author":"Funke","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0270","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1039\/b904138a","article-title":"Mirror image phage display\u2014a method to generate d-peptide ligands for use in diagnostic or therapeutical applications","volume":"5","author":"Funke","year":"2009","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ijpharm.2024.125055_b0275","doi-asserted-by":"crossref","first-page":"82331","DOI":"10.1371\/journal.pone.0082331","article-title":"Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)","volume":"9","author":"Gaillard","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2024.125055_b0280","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/chem.201404562","article-title":"Gold-Nanoparticle-Based Multifunctional Amyloid-\u03b2 Inhibitor against Alzheimer\u2019s Disease","volume":"21","author":"Gao","year":"2015","journal-title":"Chem. \u2013 A Eur. J."},{"key":"10.1016\/j.ijpharm.2024.125055_b0285","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.2174\/138161210793292555","article-title":"Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization","volume":"16","author":"Gentilucci","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijpharm.2024.125055_b0290","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpharm.2024.125055_b0295","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/1567205053585873","article-title":"The Expression of Activity-Dependent Neuroprotective Protein (ADNP) is Regulated by Brain Damage and Treatment of Mice with the ADNP Derived Peptide, NAP, Reduces the Severity of Traumatic Head Injury","volume":"2","author":"Gozes","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ijpharm.2024.125055_b0300","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2202-9-S3-S3","article-title":"NAP and D-SAL: neuroprotection against the \u03b2 amyloid peptide (1\u201342)","volume":"9","author":"Gozes","year":"2008","journal-title":"BMC Neurosci."},{"issue":"3","key":"10.1016\/j.ijpharm.2024.125055_b0305","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3233\/JAD-2010-1297","article-title":"LPYFDa neutralizes amyloid-\u03b2-induced memory impairment and toxicity","volume":"19","author":"Granic","year":"2010","journal-title":"Journal of Alzheimer\u2019s disease"},{"key":"10.1016\/j.ijpharm.2024.125055_b0310","first-page":"723","article-title":"Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer\u2019s A\u03b2 peptide. Nanomedicine Nanotechnology","volume":"13","author":"Gregori","year":"2017","journal-title":"Biol. Med."},{"key":"10.1016\/j.ijpharm.2024.125055_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.46924","article-title":"Structure-based inhibitors of amyloid beta core suggest a common interface with tau","volume":"8","author":"Griner","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.ijpharm.2024.125055_b0320","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jconrel.2023.01.074","article-title":"Brain-neuron targeted nanoparticles for peptide synergy therapy at dual-target of Alzheimer\u2019s disease","volume":"355","author":"Guo","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2024.125055_b0325","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijbiomac.2019.02.156","article-title":"Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease","volume":"130","author":"Gupta","year":"2019","journal-title":"International journal of biological macromolecules"},{"key":"10.1016\/j.ijpharm.2024.125055_b0330","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1080\/17425247.2020.1813714","article-title":"Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells","volume":"17","author":"Haggag","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2024.125055_b0335","doi-asserted-by":"crossref","first-page":"e0147488","DOI":"10.1371\/journal.pone.0147488","article-title":"Effect of Copper and Zinc on the Single Molecule Self-Affinity of Alzheimer\u2019s Amyloid-\u03b2 Peptides","volume":"11","author":"Hane","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2024.125055_b0340","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2024.125055_b0345","first-page":"1381","article-title":"Tau Consists of a Set of Proteins with Repeated C-Terminal Microtubule-Binding Domains and Variable N-Terminal Domains","volume":"9","author":"Himmler","year":"1989","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0350","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1021\/ja107675n","article-title":"Rational Design of \u03b2-Sheet Ligands Against A\u03b2 42 -Induced Toxicity","volume":"133","author":"Hochd\u00f6rffer","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2024.125055_b0355","first-page":"1541","article-title":"Rationally designed peptide-based inhibitor of A\u03b242fibril formation and toxicity: A potential therapeutic strategy for Alzheimer\u2019s disease","volume":"477","author":"Horsley","year":"2020","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpharm.2024.125055_b0360","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1042\/BCJ20200290","article-title":"Rationally designed peptide-based inhibitor of A\u03b242 fibril formation and toxicity: a potential therapeutic strategy for Alzheimer\u2019s disease","volume":"477","author":"Horsley","year":"2020","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpharm.2024.125055_b0365","article-title":"How short peptides can disassemble ultra-stable tau fibrils extracted from Alzheimer\u2019s disease brain by a strain-relief mechanism","volume":"3","author":"Hou","year":"2024","journal-title":"Res. Sq."},{"key":"10.1016\/j.ijpharm.2024.125055_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.adl2991","article-title":"D-peptide-magnetic nanoparticles fragment tau fibrils and rescue behavioral deficits in a mouse model of Alzheimer\u2019s disease","volume":"10","author":"Hou","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijpharm.2024.125055_b0375","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijpharm.2003.12.016","article-title":"Preparation and characterization of solid lipid nanoparticles containing peptide","volume":"273","author":"Hu","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2024.125055_b0380","doi-asserted-by":"crossref","first-page":"81001","DOI":"10.18632\/oncotarget.20944","article-title":"PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering A\u03b2 generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer\u2019s disease mice","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijpharm.2024.125055_b0385","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.jmb.2019.01.018","article-title":"Metal Toxicity Links to Alzheimer\u2019s Disease and Neuroinflammation","volume":"431","author":"Huat","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0390","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1073\/pnas.1220326110","article-title":"Insights into antiamyloidogenic properties of the green tea extract (\u2212)-epigallocatechin-3-gallate toward metal-associated amyloid-\u03b2 species","volume":"110","author":"Hyung","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0395","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","article-title":"A new era for understanding amyloid structures and disease","volume":"19","author":"Iadanza","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103649","article-title":"Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands","volume":"97","author":"Iraji","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0405","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002085","article-title":"Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles","volume":"8","author":"Islam","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0410","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1007\/s00044-012-0386-2","article-title":"Synthesis of d-amino acid peptides and their effect on beta-amyloid aggregation and toxicity in transgenic Caenorhabditis elegans","volume":"22","author":"Jagota","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ijpharm.2024.125055_b0415","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s12035-023-03671-7","article-title":"Current Insights of Nanocarrier - Mediated Gene Therapeutics to Treat Potential Impairment of Amyloid Beta Protein and Tau Protein in Alzheimer \u2019 s Disease","volume":"61","author":"Jain","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0420","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1039\/D1TB00126D","article-title":"Liposomes for oral delivery of protein and peptide-based therapeutics: challenges, formulation strategies, and advances","volume":"9","author":"Jash","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ijpharm.2024.125055_b0425","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1021\/bi700508n","article-title":"Redox Reactions of Copper Complexes Formed with Different \u03b2-Amyloid Peptides and Their Neuropathalogical Relevance","volume":"46","author":"Jiang","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpharm.2024.125055_b0430","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s12551-019-00606-2","article-title":"Recent advances in the design and applications of amyloid-\u03b2 peptide aggregation inhibitors for Alzheimer\u2019s disease therapy","volume":"11","author":"Jokar","year":"2019","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.ijpharm.2024.125055_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104050","article-title":"Design of peptide-based inhibitor agent against amyloid-\u03b2 aggregation: Molecular docking, synthesis and in vitro evaluation","volume":"102","author":"Jokar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0440","first-page":"51","article-title":"Amyloid \u00df-Targeted Inhibitory Peptides for Alzheimer\u2019s Disease: Current State and Future Perspectives","author":"Jokar","year":"2020","journal-title":"Exon Publications. Exon Publications"},{"key":"10.1016\/j.ijpharm.2024.125055_b0445","doi-asserted-by":"crossref","DOI":"10.3390\/bioengineering5020037","article-title":"Anti-RSV peptide-loaded liposomes for the inhibition of respiratory syncytial virus","volume":"5","author":"Joshi","year":"2018","journal-title":"Bioengineering"},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2024.125055_b0450","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0006-8993(92)91193-I","article-title":"Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease","volume":"585","author":"Kalaria","year":"1992","journal-title":"Brain research"},{"issue":"1","key":"10.1016\/j.ijpharm.2024.125055_b0455","first-page":"8147080","article-title":"Nanoparticle therapy is a promising approach in the management and prevention of many diseases: does it help in curing Alzheimer disease?","volume":"2020","author":"Kassem","year":"2020","journal-title":"Journal of Nanotechnology"},{"key":"10.1016\/j.ijpharm.2024.125055_b0460","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1271\/bbb.100388","article-title":"Selection of Peptide Inhibitors of Soluble A\u03b2 1\u201342 Oligomer Formation by Phage Display","volume":"74","author":"Kawasaki","year":"2010","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0465","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1271\/bbb.110198","article-title":"Identification of Novel Short Peptide Inhibitors of Soluble 37\/48 kDa Oligomers of Amyloid \u03b242","volume":"75","author":"Kawasaki","year":"2011","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119269","article-title":"Axial pharmaceutical properties of liposome in cancer therapy: Recent advances and perspectives","volume":"581","author":"Kiaie","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2024.125055_b0475","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.4155\/fmc-2018-0208","article-title":"Nanodelivery systems for overcoming limited transportation of therapeutic molecules through the blood-brain barrier","volume":"10","author":"Kim","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0480","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1016\/j.bmcl.2015.05.027","article-title":"Covalent modifier-type aggregation inhibitor of amyloid-\u03b2 based on a cyclo-KLVFF motif","volume":"25","author":"Kino","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijpharm.2024.125055_b0485","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1038\/s41467-019-12683-8","article-title":"Cryo-EM structure and polymorphism of A\u03b2 amyloid fibrils purified from Alzheimer\u2019s brain tissue","volume":"10","author":"Kollmer","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpharm.2024.125055_b0490","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1021\/acschemneuro.1c00164","article-title":"Hepta-Histidine Inhibits Tau Aggregation","volume":"12","author":"Kondo","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0495","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jconrel.2011.12.002","article-title":"Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity","volume":"160","author":"Koren","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2024.125055_b0500","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3390\/molecules22101693","article-title":"Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer\u2019s Disease","volume":"22","author":"Kutzsche","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ijpharm.2024.125055_b0505","doi-asserted-by":"crossref","first-page":"e202200537","DOI":"10.1002\/cbic.202200537","article-title":"D-Peptide and D-Protein Technology: Recent Advances, Challenges, and Opportunities**","volume":"24","author":"Lander","year":"2023","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ijpharm.2024.125055_b0510","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.peptides.2011.04.026","article-title":"Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer\u2019s disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library","volume":"32","author":"Larbanoix","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.ijpharm.2024.125055_b0515","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1021\/acschemneuro.2c00102","article-title":"Interaction of therapeutic d-peptides with a\u03b242 monomers, thermodynamics, and binding analysis","volume":"13","author":"Leguizamon Herrera","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0520","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejps.2016.04.016","article-title":"Pharmacokinetic properties of tandem d-peptides designed for treatment of Alzheimer\u2019s disease","volume":"89","author":"Leithold","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0525","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2009.08.002","article-title":"Clioquinol and other hydroxyquinoline derivatives inhibit A\u03b2(1\u201342) oligomer assembly","volume":"465","author":"LeVine","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijpharm.2024.125055_b0530","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1002\/smll.201202612","article-title":"Self-Assembled Peptide-Polyoxometalate Hybrid Nanospheres: Two in One Enhances Targeted Inhibition of Amyloid \u03b2-Peptide Aggregation Associated with Alzheimer\u2019s Disease","volume":"9","author":"Li","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.ijpharm.2024.125055_b0535","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1021\/jm200982p","article-title":"C-terminal tetrapeptides inhibit A\u03b242-induced neurotoxicity primarily through specific interaction at the N-terminus of A\u03b242 Huiyuan","volume":"54","author":"Li","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0540","doi-asserted-by":"crossref","first-page":"e112052","DOI":"10.1371\/journal.pone.0112052","article-title":"Feasibility of \u03b2-Sheet Breaker Peptide-H102 Treatment for Alzheimer\u2019s Disease Based on \u03b2-Amyloid Hypothesis","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2024.125055_b0545","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-2009-1162","article-title":"The Effects of Enhanced Zinc on Spatial Memory and Plaque Formation in Transgenic Mice","volume":"18","author":"Linkous","year":"2009","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ijpharm.2024.125055_b0550","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biomaterials.2015.11.060","article-title":"Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer\u2019s disease mice","volume":"80","author":"Liu","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2024.125055_b0555","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1021\/acschemneuro.8b00440","article-title":"d-Enantiomeric RTHLVFFARK-NH2: A Potent Multifunctional Decapeptide Inhibiting Cu2+-Mediated Amyloid \u03b2-Protein Aggregation and Remodeling Cu2+-Mediated Amyloid \u03b2 Aggregates","volume":"10","author":"Liu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0560","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1021\/bc400055h","article-title":"B6 Peptide-Modified PEG-PLA Nanoparticles for Enhanced Brain Delivery of Neuroprotective Peptide","volume":"24","author":"Liu","year":"2013","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0565","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/tcr.201600005","article-title":"D-Peptides as Recognition Molecules and Therapeutic Agents","volume":"16","author":"Liu","year":"2016","journal-title":"Chem. Rec."},{"key":"10.1016\/j.ijpharm.2024.125055_b0570","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/bm401795e","article-title":"Study on the Efficiency and Interaction Mechanism of a Decapeptide Inhibitor of \u03b2-Amyloid Aggregation","volume":"15","author":"Liu","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpharm.2024.125055_b0575","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejps.2017.06.002","article-title":"Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma","volume":"106","author":"Liu","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0580","doi-asserted-by":"crossref","first-page":"3702518","DOI":"10.1155\/2019\/3702518","article-title":"Smart Nanoparticles for Drug Delivery Application: Development of Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine","volume":"2019","author":"Lombardo","year":"2019","journal-title":"J. Nanomater."},{"key":"10.1016\/j.ijpharm.2024.125055_b0585","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jare.2021.05.007","article-title":"Molecular mechanisms of amyloid disaggregation","volume":"36","author":"Low","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ijpharm.2024.125055_b0590","doi-asserted-by":"crossref","first-page":"e1000334","DOI":"10.1371\/journal.pbio.1000334","article-title":"Sequestration of the A\u03b2 Peptide Prevents Toxicity and Promotes Degradation In Vivo","volume":"8","author":"Luheshi","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0595","doi-asserted-by":"crossref","first-page":"17342","DOI":"10.1073\/pnas.0506723102","article-title":"3D structure of Alzheimer\u2019s amyloid-\u03b2(1\u201342) fibrils","volume":"102","author":"L\u00fchrs","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpharm.2024.125055_b0600","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11705-017-1687-2","article-title":"Head-to-tail cyclization of a heptapeptide eliminates its cytotoxicity and significantly increases its inhibition effect on amyloid \u03b2-protein fibrillation and cytotoxicity","volume":"12","author":"Ma","year":"2018","journal-title":"Front. Chem. Sci. Eng."},{"key":"10.1016\/j.ijpharm.2024.125055_b0605","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.1074\/jbc.M707108200","article-title":"Amyloid-\u03b2 Binds to the Extracellular Cysteine-rich Domain of Frizzled and Inhibits Wnt\/\u03b2-Catenin Signaling","volume":"283","author":"Magdesian","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2024.213771","article-title":"Advances Targeted pH- and redox-responsive AuS \/ micelles with low CMC for highly efficient sonodynamic therapy of metastatic breast cancer","volume":"158","author":"Maghsoudian","year":"2024","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.ijpharm.2024.125055_b0615","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/cbic.202100287","article-title":"Potent Tau Aggregation Inhibitor D-Peptides Selected against Tau-Repeat 2 Using Mirror Image Phage Display","volume":"22","author":"Malhis","year":"2021","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ijpharm.2024.125055_b0620","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3390\/pharmaceutics14091821","article-title":"Preparation, Characterization, and Biological Evaluation of a Hydrophilic Peptide Loaded on PEG-PLGA Nanoparticles","volume":"14","author":"Marinelli","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2024.125055_b0625","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0630","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.regpep.2004.03.013","article-title":"Eight-residue A\u03b2 peptides inhibit the aggregation and enzymatic activity of A\u03b242","volume":"120","author":"Matsunaga","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ijpharm.2024.125055_b0635","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.107.130526","article-title":"A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer\u2019s Disease","volume":"325","author":"Matsuoka","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2024.125055_b0640","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.ijpharm.2024.125055_b0645","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11481-016-9698-1","article-title":"Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology","volume":"12","author":"Meng","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0650","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jinorgbio.2018.01.012","article-title":"RTHLVFFARK-NH 2: A potent and selective modulator on Cu2+ -mediated amyloid- \u03b2 protein aggregation and cytotoxicity","volume":"181","author":"Meng","year":"2018","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0655","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.ccr.2011.12.022","article-title":"Metal binding sites in amyloid oligomers: Complexes and mechanisms","volume":"256","author":"Miller","year":"2012","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ijpharm.2024.125055_b0660","doi-asserted-by":"crossref","first-page":"11242","DOI":"10.1074\/jbc.M113.537472","article-title":"Computational and Experimental Studies on \u03b2-Sheet Breakers Targeting A\u03b21\u201340 Fibrils","volume":"289","author":"Minicozzi","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120645","article-title":"An update on actively targeted liposomes in advanced drug delivery to glioma","volume":"602","author":"Mojarad-Jabali","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2024.125055_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121395","article-title":"Comparison of three synthetic transferrin mimetic small peptides to promote the blood\u2013brain barrier penetration of vincristine liposomes for improved glioma targeted therapy","volume":"613","author":"Mojarad-Jabali","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2024.125055_b0675","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17425247.2022.2083106","article-title":"Transferrin receptor-mediated liposomal drug delivery: recent trends in targeted therapy of cancer","volume":"19","author":"Mojarad-Jabali","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2024.125055_b0680","doi-asserted-by":"crossref","first-page":"7842","DOI":"10.3390\/ijms24097842","article-title":"Targeting Protein-Protein Interfaces with Peptides: The Contribution of Chemical Combinatorial Peptide Library Approaches","volume":"24","author":"Monti","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0685","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1208\/s12248-017-0110-8","article-title":"SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers","volume":"19","author":"Morris","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2024.125055_b0690","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.2147\/IJN.S165210","article-title":"Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional\/herbal medicines in cancer therapy: A systematic review","volume":"13","author":"Muhamad","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpharm.2024.125055_b0695","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.msec.2017.03.283","article-title":"Gold nanoparticles prevent cognitive deficits, oxidative stress and inflammation in a rat model of sporadic dementia of Alzheimer's type","volume":"77","author":"Muller","year":"2017","journal-title":"Materials Science and Engineering: C"},{"key":"10.1016\/j.ijpharm.2024.125055_b0700","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1021\/bi980022m","article-title":"Copper-Binding Amyloid Precursor Protein Undergoes a Site-Specific Fragmentation in the Reduction of Hydrogen Peroxide","volume":"37","author":"Multhaup","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpharm.2024.125055_b0705","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.brainresbull.2018.08.003","article-title":"Ligand conjugation: An emerging platform for enhanced brain drug delivery","volume":"142","author":"Nabi","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ijpharm.2024.125055_b0710","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4161\/mabs.27240","article-title":"Drugs derived from phage display","volume":"6","author":"Nixon","year":"2014","journal-title":"Mabs"},{"issue":"40","key":"10.1016\/j.ijpharm.2024.125055_b0715","doi-asserted-by":"crossref","first-page":"11829","DOI":"10.1039\/D2SC02593K","article-title":"Development of Cu (ii)-specific peptide shuttles capable of preventing Cu\u2013amyloid beta toxicity and importing bioavailable Cu into cells","volume":"13","author":"Okafor","year":"2022","journal-title":"Chemical Science"},{"key":"10.1016\/j.ijpharm.2024.125055_b0765","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2174\/0929867321666131129122247","article-title":"Amyloid aggregation inhibitory mechanism of arginine-rich D-peptides","volume":"21","author":"Olubiyi","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0725","doi-asserted-by":"crossref","first-page":"40302","DOI":"10.1074\/jbc.M206428200","article-title":"Metalloenzyme-like Activity of Alzheimer\u2019s Disease \u03b2-Amyloid","volume":"277","author":"Opazo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0730","doi-asserted-by":"crossref","first-page":"11882","DOI":"10.1021\/ja0619861","article-title":"Phage Display Affords Peptides that Modulate \u03b2-Amyloid Aggregation","volume":"128","author":"Orner","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2024.125055_b0735","doi-asserted-by":"crossref","first-page":"10715","DOI":"10.1039\/C5TC02043C","article-title":"Multi-phase microstructures drive exciton dissociation in neat semicrystalline polymeric semiconductors","volume":"3","author":"Paquin","year":"2015","journal-title":"J. Mater. Chem. C"},{"key":"10.1016\/j.ijpharm.2024.125055_b0740","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1006\/bbrc.2001.5243","article-title":"Zinc Enhances Synthesis of Presenilin 1 in Mouse Primary Cortical Culture","volume":"285","author":"Park","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpharm.2024.125055_b0745","doi-asserted-by":"crossref","first-page":"e54769","DOI":"10.1371\/journal.pone.0054769","article-title":"A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe\/PS1\u0394E9 Mouse Model of Alzheimer\u2019s Disease","volume":"8","author":"Parthsarathy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2024.125055_b0750","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/mp.2016.37","article-title":"Amyloid-\u03b2 and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer\u2019s disease","volume":"22","author":"Pascoal","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ijpharm.2024.125055_b0755","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00259-018-3933-3","article-title":"Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer\u2019s disease","volume":"45","author":"Pascoal","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ijpharm.2024.125055_b0760","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/pharmaceutics11110572","article-title":"Nanomedicine against A\u03b2 Aggregation by \u03b2\u2013Sheet Breaker Peptide Delivery","volume":"11","author":"Pederzoli","year":"2019","journal-title":"In Vitro Evidence. Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2024.125055_b0770","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00044-024-03269-1","article-title":"Peptide-based therapeutics: challenges and solutions","volume":"33","author":"Pereira","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ijpharm.2024.125055_b0775","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/(SICI)1097-4695(19990605)39:3<371::AID-NEU4>3.0.CO;2-E","article-title":"NL-Sheet Breaker Peptide Inhibitor of Alzheimer \u2019 s Amyloidogenesis with Increased Blood \u2013 Brain Barrier Permeability and Resistance to Proteolytic Degradation in Plasma","volume":"39","author":"Poduslo","year":"1999","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0780","doi-asserted-by":"crossref","first-page":"8002","DOI":"10.1021\/jm901092h","article-title":"Poly- N -methylated Amyloid \u03b2-Peptide (A\u03b2) C-Terminal Fragments Reduce A\u03b2 Toxicity in Vitro and in Drosophila melanogaster","volume":"52","author":"Pratim Bose","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0785","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1039\/C6CC07803F","article-title":"The synergistic effect between KLVFF and self-assembly chaperones on both disaggregation of beta-amyloid fibrils and reducing consequent toxicity","volume":"53","author":"Qu","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ijpharm.2024.125055_b0790","series-title":"Developing Therapeutics for Alzheimer\u2019s Disease: Progress and Challenges","first-page":"97","article-title":"Modulators of Amyloid \u03b2-Protein (A\u03b2) Self-Assembly","author":"Rahimi","year":"2016"},{"key":"10.1016\/j.ijpharm.2024.125055_b0795","doi-asserted-by":"crossref","first-page":"16157","DOI":"10.1074\/jbc.M500309200","article-title":"Metal Ion-dependent Effects of Clioquinol on the Fibril Growth of an Amyloid \u03b2 Peptide","volume":"280","author":"Raman","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0800","doi-asserted-by":"crossref","first-page":"16517","DOI":"10.1039\/C3RA47754A","article-title":"Self-assembly characteristics of a structural analogue of Tjernberg peptide","volume":"4","author":"Ramaswamy","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijpharm.2024.125055_b0805","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1021\/jp808914c","article-title":"Influence of preformed Asp23-Lys28 salt bridge on the conformational fluctuations of monomers and dimers of A\u03b2 peptides with implications for rates of fibril formation","volume":"13","author":"Reddy","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijpharm.2024.125055_b0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110552","article-title":"Encapsulation of an endostatin peptide in liposomes: Stability, release, and cytotoxicity study","volume":"185","author":"Rezaei","year":"2020","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.ijpharm.2024.125055_b0815","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","article-title":"Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting A\u03b2 Amyloid Deposition and Toxicity in Alzheimer Disease","volume":"60","author":"Ritchie","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0820","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/acs.accounts.5b00119","article-title":"Regulation of Copper and Iron Homeostasis by Metal Chelators: A Possible Chemotherapy for Alzheimer\u2019s Disease","volume":"48","author":"Robert","year":"2015","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ijpharm.2024.125055_b0825","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(02)00599-2","article-title":"Red blood cell copper, zinc superoxide dismutase activity is higher in Alzheimer\u2019s disease and is decreased by D-penicillamine","volume":"329","author":"Rossi","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijpharm.2024.125055_b0830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/advs.202004025","article-title":"Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release","volume":"8","author":"Ruan","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0835","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1021\/acschemneuro.8b00185","article-title":"Peptides, Peptidomimetics, and Carbohydrate-Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer\u2019s Disease","volume":"9","author":"Ryan","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0840","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2010.11.033","article-title":"Neurotherapeutic applications of nanoparticles in Alzheimer\u2019s disease","volume":"152","author":"Sahni","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2024.125055_b0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124218","article-title":"Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer\u2019s disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis","volume":"658","author":"Saleh","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2024.125055_b0850","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/pharmaceutics13081183","article-title":"Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB","volume":"13","author":"Satapathy","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2024.125055_b0855","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s13238-019-0639-7","article-title":"Phage display screening of therapeutic peptide for cancer targeting and therapy","volume":"10","author":"Saw","year":"2019","journal-title":"Protein Cell"},{"key":"10.1016\/j.ijpharm.2024.125055_b0860","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pneurobio.2014.01.002","article-title":"Metabolism and functions of copper in brain","volume":"116","author":"Scheiber","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0865","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1126\/science.271.5257.1854","article-title":"Identification of D-Peptide Ligands Through Mirror-image Phage Display","volume":"271","author":"Schumacher","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2024.125055_b0870","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nchem.2889","article-title":"Structure-based inhibitors of tau aggregation","volume":"10","author":"Seidler","year":"2018","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0875","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer\u2019s Disease: Genes, Proteins, and Therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijpharm.2024.125055_b0880","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.tips.2018.10.001","article-title":"Copper and Zinc Dysregulation in Alzheimer\u2019s Disease","volume":"39","author":"Sensi","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1109\/JTEHM.2020.3005308","article-title":"Total iron measurement in human serum with a novel smartphone-based assay","volume":"8","author":"Serhan","year":"2020","journal-title":"IEEE J. Transl. Eng. Heal. Med."},{"key":"10.1016\/j.ijpharm.2024.125055_b0890","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejmech.2019.04.060","article-title":"Multi-targeted ChEI-copper chelating molecules as neuroprotective agents","volume":"174","author":"Sestito","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0895","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jmb.2007.02.093","article-title":"The Alzheimer\u2019s Peptides A\u03b240 and 42 Adopt Distinct Conformations in Water: A Combined MD \/ NMR Study","volume":"368","author":"Sgourakis","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijpharm.2024.125055_b0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2018.06.004","article-title":"Designing a new multifunctional peptide for metal chelation and A\u03b2 inhibition","author":"Shamloo","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijpharm.2024.125055_b0905","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.1021\/ja210588m","article-title":"Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the A\u03b2 42 Peptide","volume":"134","author":"Sharma","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2024.125055_b0910","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2009.02.011","article-title":"NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model","volume":"34","author":"Shiryaev","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijpharm.2024.125055_b0915","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature10154","article-title":"Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation","volume":"475","author":"Sievers","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2024.125055_b0920","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/cbic.201600243","article-title":"Ac-LPFFD-Th: A Trehalose-Conjugated Peptidomimetic as a Strong Suppressor of Amyloid-\u03b2 Oligomer Formation and Cytotoxicity","volume":"17","author":"Sinopoli","year":"2016","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ijpharm.2024.125055_b0930","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1006\/bbrc.1996.1413","article-title":"Inhibition of Alzheimer\u2019s Amyloidosis by Peptides That Prevent \u03b2-Sheet Conformation","volume":"226","author":"Soto","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpharm.2024.125055_b0935","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0798-822","article-title":"\u03b2-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer\u2019s therapy","volume":"4","author":"Soto","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpharm.2024.125055_b0940","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neuroscience.2007.09.025","article-title":"Amyloid plaques arise from zinc-enriched cortical layers in APP\/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency","volume":"150","author":"Stoltenberg","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.ijpharm.2024.125055_b0945","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neurobiolaging.2008.03.023","article-title":"Novel phage peptides attenuate beta amyloid-42 catalysed hydrogen peroxide production and associated neurotoxicity","volume":"31","author":"Taddei","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ijpharm.2024.125055_b0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115676","article-title":"Design and synthesis of \u03b2-strand-fixed peptides inhibiting aggregation of amyloid \u03b2-protein","volume":"28","author":"Tanaka","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0955","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/bi100144m","article-title":"Development of a Proteolytically Stable Retro-Inverso Peptide Inhibitor of \u03b2-Amyloid Oligomerization as a Potential Novel Treatment for Alzheimer\u2019s Disease","volume":"49","author":"Taylor","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpharm.2024.125055_b0960","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.R800019200","article-title":"Amyloid Precursor Protein Trafficking, Processing, and Function","volume":"283","author":"Thinakaran","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b0965","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.3390\/ijms22126355","article-title":"Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer \u2019 s Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression","volume":"22","author":"Tolar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0970","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative Stress, Synaptic Dysfunction, and Alzheimer\u2019s Disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ijpharm.2024.125055_b0975","doi-asserted-by":"crossref","first-page":"17345","DOI":"10.1073\/pnas.0408153101","article-title":"In silico study of amyloid \u03b2-protein folding and oligomerization","volume":"101","author":"Urbanc","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0980","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/cmdc.200800273","article-title":"Reduction of Alzheimer\u2019s Disease Amyloid Plaque Load in Transgenic Mice by D3, a d-Enantiomeric Peptide Identified by Mirror Image Phage Display","volume":"3","author":"van Groen","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijpharm.2024.125055_b0985","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1073\/pnas.0607919104","article-title":"Multiple-motor based transport and its regulation by Tau","volume":"104","author":"Vershinin","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0990","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","article-title":"Assembly of \u03c4 protein into Alzheimer paired helical filaments depends on a local sequence motif (306 VQIVYK 311) forming \u03b2 structure","volume":"97","author":"von Bergen","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b0995","doi-asserted-by":"crossref","first-page":"48165","DOI":"10.1074\/jbc.M105196200","article-title":"Mutations of Tau Protein in Frontotemporal Dementia Promote Aggregation of Paired Helical Filaments by Enhancing Local \u03b2-Structure","volume":"276","author":"von Bergen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b1000","doi-asserted-by":"crossref","first-page":"13110","DOI":"10.3390\/ijms241713110","article-title":"Advances in Alzheimer\u2019s Disease-Associated A\u03b2 Therapy Based on Peptide","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b1005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijpharm.2024.125055_b1010","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1089\/ars.2012.5158","article-title":"Trientine Reduces BACE1 Activity and Mitigates Amyloidosis via the AGE\/RAGE\/NF-\u03baB Pathway in a Transgenic Mouse Model of Alzheimer\u2019s Disease","volume":"19","author":"Wang","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ijpharm.2024.125055_b1015","doi-asserted-by":"crossref","first-page":"e27649","DOI":"10.1371\/journal.pone.0027649","article-title":"A Peptide That Binds Specifically to the \u03b2-Amyloid of Alzheimer\u2019s Disease: Selection and Assessment of Anti-\u03b2-Amyloid Neurotoxic Effects","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2024.125055_b1020","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1016\/j.bmcl.2011.07.111","article-title":"Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer\u2019s A\u03b21\u201342 fibril formation in vitro","volume":"21","author":"Wei","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijpharm.2024.125055_b1025","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/cbic.200300631","article-title":"Selection of D-Amino-Acid Peptides That Bind to Alzheimer\u2019s Disease Amyloid Peptide A\u03b21\u201342 by Mirror Image Phage Display","volume":"4","author":"Wiesehan","year":"2003","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ijpharm.2024.125055_b1030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/cbic.200300570","article-title":"Mirror-image Phage Display: Aiming at the Mirror","volume":"4","author":"Wiesehan","year":"2003","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ijpharm.2024.125055_b1035","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3390\/molecules24122237","article-title":"Do We Need Anti-Prion Compounds to Treat Alzheimer\u2019s Disease?","volume":"24","author":"Willbold","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ijpharm.2024.125055_b1040","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature14864","article-title":"\u03b7-Secretase processing of APP inhibits neuronal activity in the hippocampus","volume":"526","author":"Willem","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2024.125055_b1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106421","article-title":"Evaluation of the 18F-labeled analog of the therapeutic all-D-enantiomeric peptide RD2 for amyloid \u03b2 imaging","volume":"184","author":"Willuweit","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b1050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2012.11.006","article-title":"The worldwide economic impact of dementia 2010","volume":"9","author":"Wimo","year":"2013","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.ijpharm.2024.125055_b1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119491","article-title":"Nanomaterial-based blood-brain-barrier (BBB) crossing strategies","volume":"224","author":"Xie","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2024.125055_b1060","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1021\/acsami.5b00915","article-title":"Design of LVFFARK and LVFFARK-Functionalized Nanoparticles for Inhibiting Amyloid \u03b2-Protein Fibrillation and Cytotoxicity","volume":"7","author":"Xiong","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijpharm.2024.125055_b1065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/smll.201601666","article-title":"Design of a Molecular Hybrid of Dual Peptide Inhibitors Coupled on AuNPs for Enhanced Inhibition of Amyloid \u03b2-Protein Aggregation and Cytotoxicity","volume":"13","author":"Xiong","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.ijpharm.2024.125055_b1070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/wnan.1623","article-title":"Phage nanofibers in nanomedicine: Biopanning for early diagnosis, targeted therapy, and proteomics analysis","volume":"12","author":"Xu","year":"2020","journal-title":"Wires Nanomedicine and Nanobiotechnology"},{"key":"10.1016\/j.ijpharm.2024.125055_b1075","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2021.116229","article-title":"Screening of specific binding peptides using phage-display techniques and their biosensing applications","volume":"137","author":"Xu","year":"2021","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.ijpharm.2024.125055_b1080","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.nbd.2012.03.013","article-title":"A multifunctional peptide rescues memory deficits in Alzheimer\u2019s disease transgenic mice by inhibiting A\u03b242-induced cytotoxicity and increasing microglial phagocytosis","volume":"46","author":"Xue","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijpharm.2024.125055_b1085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1039\/C6MT00299D","article-title":"Copper binding and redox chemistry of the A\u03b216 peptide and its variants: insights into determinants of copper-dependent reactivity","volume":"9","author":"Yako","year":"2017","journal-title":"Metallomics"},{"key":"10.1016\/j.ijpharm.2024.125055_b1090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/tcr.201200012","article-title":"Assembly of Bacteriophage into Functional Materials","volume":"13","author":"Yang","year":"2013","journal-title":"Chem. Rec."},{"key":"10.1016\/j.ijpharm.2024.125055_b1095","doi-asserted-by":"crossref","first-page":"e48540","DOI":"10.1371\/journal.pone.0048540","article-title":"A Peptide Binding to the \u03b2-Site of APP Improves Spatial Memory and Attenuates A\u03b2 Burden in Alzheimer\u2019s Disease Transgenic Mice","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2024.125055_b1100","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4103\/1673-5374.385847","article-title":"Targeting tau in Alzheimer\u2019s disease: from mechanisms to clinical therapy","volume":"19","author":"Ye","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ijpharm.2024.125055_b1105","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1039\/C7MT00184C","article-title":"Copper-finger protein of Sp1: the molecular basis of copper sensing","volume":"9","author":"Yuan","year":"2017","journal-title":"Metallomics"},{"key":"10.1016\/j.ijpharm.2024.125055_b1110","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1529\/biophysj.106.097766","article-title":"Role of Electrostatic Interactions in Amyloid \u03b2-Protein (A\u03b2) Oligomer Formation: A Discrete Molecular Dynamics Study","volume":"92","author":"Yun","year":"2007","journal-title":"Biophys. J."},{"issue":"10","key":"10.1016\/j.ijpharm.2024.125055_b1115","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1021\/ja00036a073","article-title":"A racemic protein","volume":"114","author":"Zawadzke","year":"1992","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/j.ijpharm.2024.125055_b1120","doi-asserted-by":"crossref","first-page":"1050647","DOI":"10.3389\/fnut.2022.1050647","article-title":"Nanocarrier system: An emerging strategy for bioactive peptide delivery","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.ijpharm.2024.125055_b1125","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.biomaterials.2013.09.063","article-title":"Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer\u2019s disease mice","volume":"35","author":"Zhang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2024.125055_b1130","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1002\/1873-3468.12871","article-title":"A mimotope of A\u03b2 oligomers may also behave as a \u03b2-sheet inhibitor","volume":"591","author":"Zhang","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijpharm.2024.125055_b1135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmr.2697","article-title":"Design of nonapeptide LVFFARKHH: A bifunctional agent against Cu 2+ -mediated amyloid \u03b2-protein aggregation and cytotoxicity","volume":"31","author":"Zhang","year":"2018","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.ijpharm.2024.125055_b1140","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1021\/acschemneuro.0c00518","article-title":"Selection of a d-Enantiomeric Peptide Specifically Binding to PHF6 for Inhibiting Tau Aggregation in Transgenic Mice","volume":"11","author":"Zhang","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijpharm.2024.125055_b1145","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1021\/acschemneuro.1c00035","article-title":"Brain Targeting and A\u03b2 Binding Bifunctional Nanoparticles Inhibit Amyloid Protein Aggregation in APP\/PS1 Transgenic Mice","volume":"12","author":"Zhang","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijpharm.2024.125055_b1150","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.3390\/ijms22136842","article-title":"A Novel Cu(II)-Binding Peptide Identified by Phage Display Inhibits Cu2+-Mediated A\u03b2 Aggregation","volume":"22","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b1155","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.7150\/thno.68636","article-title":"Phage display derived peptides for Alzheimer\u2019s disease therapy and diagnosis","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.ijpharm.2024.125055_b1160","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jconrel.2014.07.050","article-title":"The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer\u2019s disease","volume":"192","author":"Zhang","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2024.125055_b1165","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1039\/C9BM00676A","article-title":"Screening a specific Zn (ii)-binding peptide for improving the cognitive decline of Alzheimer\u2019s disease in APP\/PS1 transgenic mice by inhibiting Zn 2+-mediated amyloid protein aggregation and neurotoxicity","volume":"7","author":"Zhang","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ijpharm.2024.125055_b1170","first-page":"1","article-title":"Oxidative Stress and the Pathogenesis of Alzheimer\u2019s Disease","volume":"2013","author":"Zhao","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ijpharm.2024.125055_b1175","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1007\/s11095-015-1744-9","article-title":"Intranasal H102 Peptide-Loaded Liposomes for Brain Delivery to Treat Alzheimer\u2019s Disease","volume":"32","author":"Zheng","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2024.125055_b1180","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.actbio.2016.11.029","article-title":"A hybrid siRNA delivery complex for enhanced brain penetration and precise amyloid plaque targeting in Alzheimer\u2019s disease mice","volume":"49","author":"Zheng","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpharm.2024.125055_b1185","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2017.04.033","article-title":"Dual-functional nanoparticles for precise drug delivery to Alzheimer\u2019s disease lesions: Targeting mechanisms, pharmacodynamics and safety","volume":"525","author":"Zheng","year":"2017","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517324012894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517324012894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:24:13Z","timestamp":1740115453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517324012894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":236,"alternative-id":["S0378517324012894"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2024.125055","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptide-based inhibitors and nanoparticles: Emerging therapeutics for Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2024.125055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125055"}}